Fed Governor Under Fire, White House Wants Intel Stake, Trump Slams Renewables

Thank you for being a Global Market News Subscriber!

Today’s Top Stories:

🏦

Mortgage Fraud Bombshell: Trump Demands Fed Governor Resign

After hitting fresh highs, Bitcoin and other major tokens are retreating. Here’s what triggered the drop—and what investors should watch next.

👉 Read the Full Story

💻

Is Intel ‘Too Strategic to Fail’? The White House Wants 10%

The Biden administration handed out subsidies—Trump wants equity. A potential government stake in Intel raises big questions for investors in tech and national security-sensitive industries.

👉 Get the Full Breakdown

Former Zillow exec targets $1.3T market

The wealthiest companies tend to target the biggest markets. For example, NVIDIA skyrocketed nearly 200% higher in the last year with the $214B AI market’s tailwind.

That’s why investors are so excited about Pacaso.

Created by a former Zillow exec, Pacaso brings co-ownership to a $1.3 trillion real estate market. And by handing keys to 2,000+ happy homeowners, they’ve made $110M+ in gross profit to date. They even reserved the Nasdaq ticker PCSO.

No wonder the same VCs behind Uber, Venmo, and eBay also invested in Pacaso. And for just $2.90/share, you can join them as an early-stage Pacaso investor today.

Invest for $2.90/Share

_{Paid advertisement for Pacaso’s Regulation A offering. Read the offering circular at invest.pacaso.com. Reserving a ticker symbol is not a guarantee that the company will go public. Listing on the NASDAQ is subject to approvals.}

☀️

Trump Declares No More Solar or Wind Approvals: What It Means for Investors

Peter Navarro calls out India’s crude purchases, raising questions about U.S.-India relations, global energy flows, and trade policy risks.

👉 Read the full article

❤️

A Bullish "Diagnosis" from Wall Street

Some Wall Street analysts project this stock will reach $14 by next year. But you can still invest for $3.50.

HeartSciences (Nasdaq: HSCS) is using AI to make ECGs better at detecting heart disease earlier. Their software platform can be used with existing ECGs-a device used 1 billion times yearly.

Shares have closed as high as $5.73 this month, and they're targeting FDA submission this year.

👉 Invest at $3.50 in HeartSciences Here

This is a paid advertisement for HeartSciences Regulation A+ offering. Please read the offering circular at invest.heartsciences.com

Want to advertise in Global Market News?

If your company is interested in reaching an audience of engaged and informed investors.👉 Click here to learn more